Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Arctic Bioscience AS ( (DE:9TD) ) has provided an update.
Arctic Bioscience has launched Romega® Skin Refine, a dietary supplement aimed at the global beauty and skincare market, which is valued at approximately 550-700 billion USD and growing at 7-8% annually. The product, which combines herring roe oil with other skin-beneficial ingredients, will initially be available in Sweden and China, with plans for further European expansion. This launch marks a significant step in Arctic Bioscience’s strategy to expand its direct-to-consumer offerings and set new standards in natural skincare.
More about Arctic Bioscience AS
Arctic Bioscience is a biotechnology company that specializes in developing and commercializing pharmaceutical products and dietary supplements derived from unique bioactive marine raw materials. The company is particularly focused on creating new treatments for conditions such as mild-to-moderate psoriasis and offers a range of dietary supplements under the ROMEGA® brand.
Average Trading Volume: 29,828
Current Market Cap: NOK98.04M
Find detailed analytics on 9TD stock on TipRanks’ Stock Analysis page.